Group 1 - The core point of the news is that President Trump has threatened pharmaceutical companies with a potential 200% tariff on imported drugs, but the market has reacted calmly due to the provided grace period for companies to adjust [1][2] - The grace period of "one to one and a half years" allows pharmaceutical companies ample time to stockpile and shift production, significantly reducing investor concerns [1][2] - Major pharmaceutical companies are already taking proactive measures, such as stockpiling drugs and increasing domestic production investments, indicating that industry confidence remains intact despite tariff threats [1][3] Group 2 - The grace period could extend until 2027, and companies may further extend their response time to 2028 through stockpiling, providing a strategic planning window for long-term adjustments [2] - The pharmaceutical industry is accelerating stockpiling, with hormone drug exports from Ireland to the U.S. valued at $36 billion this year, more than double last year's total [3] - Companies like Eli Lilly are investing heavily in U.S. manufacturing, with a $27 billion expansion plan, and tax incentives from Trump's "Big Beautiful Plan" are helping to mitigate the costs of establishing new facilities [3]

Core Viewpoint - The case of a young patient developing cataracts due to long-term use of steroid medications highlights the potential risks associated with such treatments, particularly in dermatological conditions [1][3]. Group 1: Patient Case Summary - A 22-year-old patient, referred to as Xiao Zhang, experienced a significant decline in vision, ultimately diagnosed with cataracts [1][3]. - The cataract was attributed to over a year of steroid and biological agent use for treating neurodermatitis, which led to the development of steroid-induced cataracts [3]. Group 2: Medical Insights - Steroid-induced cataracts are a common type of cataract resulting from prolonged use of steroid medications, either orally or topically [3]. - The exact mechanism of steroid-induced cataracts is not fully understood, but it may involve glucocorticoid receptor mediation and abnormal cell adhesion [3]. - Patients using steroids for extended periods may face progressive eye-related side effects, necessitating regular eye examinations [4]. Group 3: Treatment and Recovery - The medical team proposed a surgical solution involving femtosecond laser-assisted implantation of a trifocal intraocular lens, which successfully restored the patient's vision to 1.0 within a day post-surgery [3].